Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. H. Lundbeck A/S
  6. News
  7. Summary
    LUN   DK0010287234


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

H Lundbeck A/S : Lundbeck CEO, Deborah Dunsire, warns that we could be on the brink of a COVID-19 mental health crisis

06/11/2021 EDT

After a year of lockdowns and social isolation, the signs of its consequences are beginning to show and can impact public health on a global scale. That is the warning from Lundbeck CEO, Deborah Dunsire, who fears that COVID-19 can damage the mental health wellbeing of people both directly and indirectly. She further says that it will demand collaboration between governments, civic society, private businesses, and academia to address the health challenge.

'Every single person on the planet has been impacted by COVID-19. We see an increase of not only anxiety and depression but also post-traumatic stress.'

She points to several studies that examine the long-term effects of COVID-19 on people's mental health. One of the most thorough studies to date is an article in Lancet showing that a third of COVID-19 patients develop neurological or psychiatric disorders in the following six months after their COVID-infection.1

In parallel with the direct mental health consequences of COVID, a year of lockdown, social isolation, and stressful situations, people's mental health is worsening. More than 42% of people surveyed by the US Census Bureau in December reported symptoms of anxiety or depression in December.2

According to Deborah Dunsire, the private, as well as the public sector, must work together to avoid an uncontrollable crisis.

'We need to act together to come up with solutions for this crisis, companies, governments, academia, and civil society. We know that we can find solutions when experts come together, and that is why we at Lundbeck say: Let's talk about this issue so we can come up with the best solutions to prevent this mental health crisis,' says Deborah Dunsire, who is calling for collaboration.

We know that a delay in treatment of mental diseases can have a negative impact on the long-term prospects of recovery. deborah dunsire, president & CEO, Lundbeck

1. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records - The Lancet Psychiatry - link seen 27 May 2021

2. COVID's mental-health toll: how scientists are tracking a surge in depression (nature.com) - link seen 27 May 2021


H. Lundbeck A/S published this content on 11 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 June 2021 13:29:04 UTC.

ę Publicnow 2021
All news about H. LUNDBECK A/S
07/22H LUNDBECK A/S : What do you mean brain health?
07/01Denovo Biopharma LLC Announces In-Licenses Late-Stage Alzheimer's Disease Ass..
06/15#1VOICESUMMIT : Partnering with the advocacy community to further brain health a..
06/11H LUNDBECK A/S : Lundbeck CEO, Deborah Dunsire, warns that we could be on the br..
05/31H LUNDBECK A/S : Interpretation Of The Term "export" In The Indian Patent Contex..
05/26H LUNDBECK A/S : Transactions with shares and linked securities in H. Lundbeck A..
05/24H LUNDBECK A/S : The Hunt for a New Weapon Against Schizophrenia
05/20Verantos and Lundbeck Announce Partnership for Migraine Care Implementing Adv..
05/11H LUNDBECK A/S : Lundbeck delivers a solid EBIT of DKK 882 million and Vyepti is..
05/11H. Lundbeck A/S Provides Revenue Guidance for the Full Year of Fiscal 2021
More news
Sales 2021 16 633 M 2 659 M 2 659 M
Net income 2021 1 490 M 238 M 238 M
Net Debt 2021 2 251 M 360 M 360 M
P/E ratio 2021 28,0x
Yield 2021 1,64%
Capitalization 38 369 M 6 132 M 6 134 M
EV / Sales 2021 2,44x
EV / Sales 2022 2,16x
Nbr of Employees 5 551
Free-Float 30,7%
Duration : Period :
H. Lundbeck A/S Technical Analysis Chart | LUN | DK0010287234 | MarketScreener
Technical analysis trends H. LUNDBECK A/S
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 15
Last Close Price 193,10 DKK
Average target price 240,93 DKK
Spread / Average Target 24,8%
EPS Revisions
Managers and Directors
Deborah L. Dunsire President & Chief Executive Officer
Anders G÷tzsche Chief Financial Officer & Executive Vice President
Lars S°ren Rasmussen Chairman
Lars Bang Executive VP-Supply Operations & Engineering
Johan Luthman EVP & Head-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
H. LUNDBECK A/S-9.58%5 955
JOHNSON & JOHNSON9.40%453 418
ROCHE HOLDING AG12.49%332 374
PFIZER, INC.16.25%243 220
NOVARTIS AG0.39%223 750